Free Trial

Allogene Therapeutics (ALLO) SEC Filings & 10K Form

Allogene Therapeutics logo
$1.06 -0.03 (-2.75%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.06 0.00 (-0.09%)
As of 05/23/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Allogene Therapeutics SEC Filings

DateFilerForm TypeView
05/13/2025
10:44 AM
Allogene Therapeutics (Subject)
Capital World Investors (Filed by)
Form SCHEDULE 13G
05/09/2025
4:49 PM
Allogene Therapeutics (Subject)
Chang David D (Filed by)
Form SCHEDULE 13G/A
05/09/2025
4:30 PM
Allogene Therapeutics (Subject)
Belldegrun Arie (Filed by)
Form SCHEDULE 13G/A
04/23/2025
4:28 PM
Allogene Therapeutics (Issuer)
Yoshiyama Annie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
3:49 PM
Allogene Therapeutics (Subject)
Yoshiyama Annie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2025
8:35 AM
Allogene Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
03/18/2025
4:28 PM
Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:30 PM
Allogene Therapeutics (Issuer)
Chang David D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
9:01 AM
Allogene Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
03/05/2025
3:11 PM
Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:58 PM
Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2025
8:02 AM
Allogene Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
Form SCHEDULE 13G
02/05/2025
3:16 PM
Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:32 PM
Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
3:28 PM
Allogene Therapeutics (Subject)
Parker Geoffrey M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
7:35 AM
Allogene Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
7:10 PM
Allogene Therapeutics (Issuer)
Chang David D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:11 PM
Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:13 PM
Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:14 PM
Allogene Therapeutics (Issuer)
Yoshiyama Annie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:15 PM
Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:16 PM
Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:30 PM
Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:22 PM
Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:53 PM
Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
1:15 PM
Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
Form 144/A
12/02/2024
1:11 PM
Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
9:57 AM
Allogene Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/23/2024
3:21 PM
Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
2:24 PM
Allogene Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
06/20/2024
3:31 PM
Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:33 PM
Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:30 PM
Allogene Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:28 PM
Allogene Therapeutics (Issuer)
Kazam Joshua A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:29 PM
Allogene Therapeutics (Issuer)
WITTE OWEN N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:30 PM
Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:33 PM
Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:34 PM
Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:35 PM
Allogene Therapeutics (Issuer)
Mayo Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:25 PM
Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:09 PM
Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump Predicts Dollar Downfall (Ad)

READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?

Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now.
05/29/2024
1:08 PM
Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALLO) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners